AI Panic? More Like AI Opportunity (If You Don’t Lose Your Cool)
So here's what happened yesterday: Someone at Citrini Research basically yelled "FIRE!" in a crowded theater, except the theater was the stock market and the fire was... artificial intelligence taking over everything. Cue dramatic selloff. The S&P 500 dropped 1% faster than your Wi-Fi when you're trying to stream Netflix during peak hours. IBM? Oh boy, IBM had its worst day in 25 years. Twenty-five years! That's like... since dial-up internet was a thing. But here's the plot twist nobody saw coming: ...
Read More About This
Read More About This
When Smart Money Gets Dumb: Why This Top Economist Thinks We’re All About to Get Schooled
You know that feeling when everyone at the party is having way too much fun, and you're the only one wondering who's going to clean up the mess? That's basically where top economist Mark Zandi finds himself right now, watching the markets party like it's 2021 while the actual economy is nursing a hangover. Zandi, who's the chief economist at Moody's Analytics (fancy title for "guy who's really good at seeing economic train wrecks coming"), just issued what amounts to a ...
Read More About This
Read More About This
The Government Just Broke Its Own Rules (And Your Portfolio Should Care)
Remember when building anything in America required navigating more red tape than a Christmas present? Well, plot twist: the government just decided those rules don't apply anymore. At least not if you're building the future. While everyone was arguing about election maps and Twitter drama, something way more important was happening in the basement of bureaucracy. The feds basically said "screw it" to decades of regulatory gridlock and flipped the switch on what I'm calling the "One Rule" economy. Here's the deal: ...
Read More About This
Read More About This
That Awkward Moment When a Top Economist Says the Market is Living in Fantasy Land
So here's the thing about economists – they're usually about as exciting as watching paint dry on a rainy Tuesday. But when Mark Zandi from Moody's Analytics starts waving red flags about the stock market, you might want to put down your avocado toast and pay attention. Zandi just dropped what's basically the economic equivalent of "we need to talk" – and spoiler alert, it's not good news. He's saying the stock market and the actual economy have basically become that ...
Read More About This
Read More About This
Royal Caribbean Insiders Just Dumped $166 Million — Here’s What They See
When one insider sells, it's a tax bill. When the entire C-suite sells at the same time, it's a warning flare. Over the past two weeks, Royal Caribbean's executive team has unloaded a staggering $166 million worth of stock. The CEO sold 7,854 shares. The CFO dumped 51,131 shares. Two directors collectively sold 281,385 shares. The chief accounting officer and two other executives also hit the sell button. At over $300 per share, the numbers add up fast — and the ...
Read More About This
Read More About This
Domino’s Just Proved the American Consumer Isn’t Dead Yet
In a market getting pummeled by tariff anxiety and tech selloffs, Domino's Pizza did something radical on Monday: it went up. Shares surged 6% after the pizza giant dropped a Q4 earnings report that showed exactly what Wall Street wanted to see — growth, cash flow, and a fat dividend hike. Revenue hit $1.54 billion, up 6.4% year over year and topping the $1.52 billion consensus estimate. U.S. same-store sales grew 3.7%, beating the 3.47% analysts had penciled in. The only ...
Read More About This
Read More About This
Gilead Drops $7.8 Billion on a Cancer Drug That Hasn’t Been Approved Yet
Just days after CEO Daniel O'Day told investors M&A wasn't an urgent priority, Gilead Sciences dropped $7.8 billion to gobble up Arcellx — the biotech partner it's been courting since 2022. The deal pays Arcellx shareholders $115 per share in cash, a 79% premium to Friday's close. Shares of Arcellx rocketed 78% on the news Monday morning. Gilead dipped about 1%. Classic acquirer-target dynamic — the buyer always bleeds a little. The prize is anito-cel, an investigational CAR-T cell therapy targeting multiple ...
Read More About This
Read More About This
The Government Just Broke Its Own Rules (And Your Portfolio Should Care)
Remember when building anything in America took longer than a Marvel movie franchise? Well, plot twist: the government just hit the fast-forward button, but only for their favorite kids. While everyone was arguing about politics on Twitter, something way more important was happening in the basement of bureaucracy. The feds basically said "screw the red tape" when it comes to AI infrastructure. They're calling it the "One Rule" economy, and honestly, it's the biggest policy shift since someone decided the internet ...
Read More About This
Read More About This